Ozoralizumab, CAS 1167985-17-2

Product Description: Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Ishiwatari-Ogata C, et, al. Ozoralizumab, a Humanized Anti-TNFα NANOBODY® Compound, Exhibits Efficacy Not Only at the Onset of Arthritis in a Human TNF Transgenic Mouse but Also During Secondary Failure of Administration of an Anti-TNFα IgG. Front Immunol. 2022 Feb 22;13:853008.

CAS Number: 1167985-17-2

Molecular Weight: N/A

Compound Purity: 99.80

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: TNF Receptor

• SKU: MEXHY-P99796-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99796-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated